William F. Doyle, Executive Chairman at NovoCure Ltd (NVCR), sold 133,777 shares at $95.00 ($12.7M) on 2020-01-17, disclosed to the SEC on 2020-01-22.
Open-market sale of $12.7M NVCR by Executive Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ELAN | BUY | 2024-03-12 | $245K | — | Filing → |
| NVCR | SELL | 2022-08-03 | $117K | — | Filing → |
| NVCR | SELL | 2022-03-09 | $334K | — | Filing → |